Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGR-hTNF + XELOX in Metastatic Colorectal Cancer
NCT00675012Phase 2Completed
- Sponsor
- AGC Biologics
- Start
- Dec 2007
- Primary completion
- Dec 2010
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of NGR-TNF in metastatic colorectal cancer (mCRC), sponsored by AGC Biologics. Started Dec 2007; status: completed.
02
Drugs
NGR-TNF
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00675012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675012.